Pliant Therapeutics, Inc. Common Stock (PLRX) is a publicly traded Healthcare sector company. As of November 9, 2026, PLRX trades at $0.81 with a market cap of $50.14M and a P/E ratio of -0.43. PLRX moved +0.00% today. Year to date, PLRX is -35.22%; over the trailing twelve months it is -47.08%. Its 52-week range spans $0.80 to $1.95. Analyst consensus is neutral with an average price target of $2.50. Rallies surfaces PLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PLRX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.81 |
| Market Cap | $50.14M |
| P/E Ratio | -0.43 |
| EPS | $-2.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.95 |
| 52-Week Low | $0.80 |
| Volume | 26.62K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-149.34M |
| Gross Margin | 0.00% |
5 analysts cover PLRX: 0 strong buy, 0 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.50.